MENS - Jyong Biotech Ltd. News

Discover

MENS

Jyong Biotech Ltd.

1.88

2 x 1.51

2 x 2.56

bid

ask

0.00

0.00%

2 @ 04:00 PM

1.88 +0.00 (0.00%)

Ytd	-52.41%
1y	-95.82%

1.84

day range

1.96

1.43

52 week range

45.42

Open	1.91	Prev Close	1.88	Low	1.84	High	1.96	Mkt Cap	142.93M
Vol	18.78K	Avg Vol	42.86K	EPS	-0.06	P/E	N/A	Forward P/E	N/A
Beta	N/A	Short Ratio	0.56	Inst. Own	0.14%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	11-12	50-d Avg	2.08	200-d Avg	2.16	1yr Est	0.00

MENS News

globenewswire.com

Jyong Biotech to Host Two-Day Investor Events in Silicon Valley and Irvine, California

New Taipei City, Taiwan/San Francisco, CA, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nas

benzinga.com

Jyong Biotech Plans Potential Texas Manufacturing Facility And U.S. Operations Center To Support Fut

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

globenewswire.com

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug C

New Taipei City, Taiwan, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "C

globenewswire.com

Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow

New Taipei City, Taiwan/San Francisco, CA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd.

globenewswire.com

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic

New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "C

globenewswire.com

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market

globenewswire.com

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Co

globenewswire.com

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Co

benzinga.com

Jyong Biotech Advances Market Access Strategies For Its Plant-Based Drugs Botreso And PCP After Anal

As previously announced, its first core product, Botreso®, has completed four Phase III clinical tri

globenewswire.com

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple C

New Taipei City, Taiwan, April 28, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “

defenseworld.net

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March

Jyong Biotech Ltd. (NASDAQ: MENS - Get Free Report) was the recipient of a large decline in short in

globenewswire.com

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative

New Taipei City, Taiwan, March 27, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “

benzinga.com

12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com

Jyong Biotech Completes Phase II Trial For MCS-8, Expands Commercial Presence In Asia

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostat

globenewswire.com

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Ph

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostat

benzinga.com

Jyong Biotech Announces Updated Statistical Analyses For Key Blood Biochemical Markers From Phase II

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

globenewswire.com

Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-

New Taipei City, Taiwan, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

benzinga.com

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving I

benzinga.com

Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday

benzinga.com

Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com

US Stocks Higher; Nasdaq Surges Over 100 Points

benzinga.com

Jyong Biotech Reaffirms Compliance With Disclosure Obligations Under SEC Regulations, In Discussions

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech") notes the recen

globenewswire.com

Jyong Biotech Responds to Share Price and Volume Movement

New Taipei City, Taiwan, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

defenseworld.net

Jyong Biotech Ltd.’s (NASDAQ:MENS) Lock-Up Period Will End on December 15th

Jyong Biotech's (NASDAQ: MENS - Get Free Report) lock-up period is set to end on Monday, December 15

benzinga.com

Jyong Biotech Enters Into Non-Binding MOU With Vietnam‑Based Pharmaceutical Distribution Company To

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

globenewswire.com

Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for

New Taipei City, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

benzinga.com

Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On

benzinga.com

Jyong Biotech Signs MoU With South Korean Pharmaceutical Company To Review, Evaluate Licensing, Deve

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driv

globenewswire.com

Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Compa

New Taipei City, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

benzinga.com

Jyong Biotech Completes Statistical Analysis Of Primary Efficacy Endpoints In Ongoing Phase II Clini

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

globenewswire.com

Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Tr

New Taipei City, Taiwan, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stock

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%

Trump's second term is fueling an IPO comeback, with 2025 listings up 50% and five stocks alread

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

globenewswire.com

Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards

New Taipei City, Taiwan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd.

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session